ARCHIVES

Phase III Nexavar Trial Fails Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

Cancer Education Applications Suspended Pending Restructuring

March 21, 1986

FDA Places Controls On Silicone Implants, Though Still Available For Reconstruction

April 25, 1992

Abstracts From AACR Annual Meeting

June 4, 1976

MGMT Gene Can Determine Disease Aggressiveness

June 24, 2011

Matted Lymph Nodes Can Predict Survival Rate, Spread of Disease

January 27, 2012

Also New AACR President Lynn Matrisian plans emphasis on enhancing communication.

April 2, 2004